Loading
Latest filing published 05 Apr 2017 for Abattis Bioceuticals Corp..
No signal scores available.
All filings by Douglas Sorocco on record concern Abattis Bioceuticals Corp. Between 21 August 2012 and 24 March 2017, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 5 April 2017 with a share grant in Abattis Bioceuticals Corp. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations